Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
11 studies found for:    COL-144
Show Display Options
Rank Status Study
1 Completed Dose-ranging Study of Oral COL-144 in Acute Migraine Treatment
Condition: Migraine Disorders
Interventions: Drug: COL-144;   Drug: Placebo
2 Completed A Placebo-Controlled Adaptive Treatment Assignment Study of Intravenous COL-144 in the Acute Treatment of Migraine
Condition: Migraine
Intervention: Drug: COL-144
3 Completed Absorption, Metabolism and Excretion of [14C]-Lasmiditan - Single Oral Dose Administration
Condition: Pharmacokinetics
Intervention: Drug: [14C]-lasmiditan
4 Completed
Has Results
Food-Effect Study in Healthy Subjects
Condition: Bioavailability Under Fed and Fasted Conditions
Intervention: Drug: Lasmiditan
5 Recruiting Study of Oral Lasmiditan in Subjects With Normal and Impaired Renal Function
Condition: Migraine
Intervention: Drug: Lasmiditan
6 Enrolling by invitation An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
Condition: Acute Treatment of Migraine in Adults
Interventions: Drug: lasmiditan 100 mg;   Drug: lasmiditan 200 mg
7 Completed Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Subjects
Condition: Acute Treatment of Migraine
Interventions: Drug: lasmiditan 200 mg;   Drug: Sumatriptan;   Drug: matching placebo
8 Completed Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
Condition: Acute Migraine
Interventions: Drug: Lasmiditan 100 mg;   Drug: Lasmiditan 200 mg;   Drug: Placebo (matches lasmiditan doses)
9 Active, not recruiting Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine
Condition: Acute Migraine
Interventions: Drug: Lasmiditan 50 mg;   Drug: Lasmiditan 100 mg;   Drug: Lasmiditan 200 mg;   Drug: Placebo
10 Active, not recruiting The Effects of Lasmiditan on Simulated Driving Performance - Healthy Volunteers
Condition: Migraine
Interventions: Drug: Lasmiditan;   Drug: Alprazolam;   Other: placebo
11 Recruiting Pharmacokinetic Single Dose Study of Oral Lasmiditan in Subjects With Normal and Impaired Hepatic Function
Condition: Migraine
Intervention: Drug: lasmiditan 200 mg

Study has passed its completion date and status has not been verified in more than two years.